Works matching IS 03125963 AND DT 2023 AND VI 62 AND IP 4
Results: 11
Correction to: Pharmacokinetics, Safety, and Tolerability of Glepaglutide, a Long-Acting GLP-2 Analog, in Subjects with Renal Impairment.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 4, p. 653, doi. 10.1007/s40262-023-01236-4
- By:
- Publication type:
- Article
External Evaluation of Population Pharmacokinetic Models for Precision Dosing: Current State and Knowledge Gaps.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 4, p. 533, doi. 10.1007/s40262-023-01233-7
- By:
- Publication type:
- Article
Evaluation of CYP2C19-Mediated Pharmacokinetic Drug Interaction of Tegoprazan, Compared with Vonoprazan or Esomeprazole.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 4, p. 599, doi. 10.1007/s40262-023-01228-4
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Ruxolitinib: A Review.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 4, p. 559, doi. 10.1007/s40262-023-01225-7
- By:
- Publication type:
- Article
Clinical Pharmacokinetics and Pharmacodynamics of CSL112.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 4, p. 541, doi. 10.1007/s40262-023-01224-8
- By:
- Publication type:
- Article
Effect of Various Dosing Schedules on the Pharmacokinetics of Oral Semaglutide: A Randomised Trial in Healthy Subjects.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 4, p. 635, doi. 10.1007/s40262-023-01223-9
- By:
- Publication type:
- Article
Assessing the Impact of Immunogenicity and Improving Prediction of Trough Concentrations: Population Pharmacokinetic Modeling of Adalimumab in Patients with Crohn's Disease and Ulcerative Colitis.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 4, p. 623, doi. 10.1007/s40262-023-01221-x
- By:
- Publication type:
- Article
Population Pharmacokinetics and Dosing Simulations of Ampicillin and Sulbactam in Hospitalised Adult Patients.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 4, p. 573, doi. 10.1007/s40262-023-01219-5
- By:
- Publication type:
- Article
Pharmacokinetics, Safety, and Tolerability of Glepaglutide, a Long-Acting GLP-2 Analog, in Subjects with Renal Impairment.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 4, p. 645, doi. 10.1007/s40262-023-01215-9
- By:
- Publication type:
- Article
Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor (FXR) Agonist.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 4, p. 609, doi. 10.1007/s40262-023-01214-w
- By:
- Publication type:
- Article
Population Pharmacokinetics and Exposure–Response Analysis for the Phase 3 COSMIC-311 Trial of Cabozantinib for Radioiodine-Refractory Differentiated Thyroid Cancer.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 4, p. 587, doi. 10.1007/s40262-023-01210-0
- By:
- Publication type:
- Article